GU CONNECT has summarised the highlights of the recent congress of the American Society of Clinical Oncology GU (ASCO GU) 2017 in Orlando, USA for you
Prostate Cancer by Asst. Prof. Alicia Morgans
GU CONNECT has summarised the highlights of the recent congress of the American Society of Clinical Oncology GU (ASCO GU) 2017 in Orlando, USA for you
Prostate Cancer by Asst. Prof. Alicia Morgans
Dr Morgans is Genitourinary Medical Oncologist at Dana-Farber Cancer Institute, and Faculty in Medicine at Harvard Medical School in Boston, MA. She completed medical school and residency at the University of Pennsylvania School of Medicine, fellowship in Hematology/Oncology at Harvard’s Dana Farber Cancer Institute and Massachusetts General Hospital Cancer Center in Boston and earned a Master of Public Health at Vanderbilt University. Dr Morgans treats patients with prostate, bladder, and testicular cancer, and her research assesses complications of advanced prostate cancer survivorship and patient-centered treatment decision-making in advanced prostate cancer.
AAA, Astellas, AstraZeneca, Bayer, Exelixis, Janssen, Myovant, Novartis, Pfizer, Sanofi and Telix.
Make decisions for your patient at two key stages in their journey
Experts discuss new lung cancer data at a meeting hosted by eChinaHealth and COR2ED
Share the survey with patients with lung cancer and their caregivers
Explore pre-analytical phase challenges and biomarker testing in lung cancer. Moderated by the Oncology Brothers.
Follow a patient's journey during and post-elacestrant treatment for ER+/HER2- metastatic breast cancer
Moderated by the Oncology Brothers. Episode 2 of a 3-part video podcast series